miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma
Cell Reports · 2025
DOI: 10.1016/j.celrep.2024.115171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Enrico Pozzo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Herestraat 49, 30…. Hauptthemen laut MEDLINE: MicroRNAs, Rhabdomyosarcoma, Cellular Reprogramming. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Stichting Tegen Kanker, KU Leuven.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: enrico.pozzo@kuleuven.be.
- Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
- Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Herestraat 49, 3000 Leuven, Belgium; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of On…
- Laboratory of Stem Cell and Developmental Epigenetics, Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
- Translational Cardiomyology Laboratory, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium; Clinical and Experimental Endocrinology (CEE), KU…
- Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, 3000 Leuven, Belgium.
Förderung
- NCI NIH HHS
- Stichting Tegen Kanker
- KU Leuven
- Ministero della Salute
- Interreg
- Fonds Wetenschappelijk Onderzoek
- Gilead Sciences
- Merck
Zitieren
APA
Pozzo, E., Yedigaryan, L., Giarratana, N., Wang, C. C., Garrido, G. M., Degreef, E., Marini, V., Rinaldi, G., van der Veer, B. K., Sassi, G., Eelen, G., Planque, M., Fanzani, A., Koh, K. P., Carmeliet, P., Yustein, J. T., Fendt, S. M., Uyttebroeck, A., & Sampaolesi, M. (2025). miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115171
Vancouver
Pozzo E, Yedigaryan L, Giarratana N, Wang CC, Garrido GM, Degreef E, et al. miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma. Cell Reports. 2025. doi:10.1016/j.celrep.2024.115171
BibTeX
@article{Pozzo2025,
author = {Pozzo, Enrico and Yedigaryan, Laura and Giarratana, Nefele and Wang, Chao-Chi and Garrido, Gabriel Miró and Degreef, Ewoud and Marini, Vittoria and Rinaldi, Gianmarco and van der Veer, Bernard K and Sassi, Gabriele and Eelen, Guy and Planque, Mélanie and Fanzani, Alessandro and Koh, Kian Peng and Carmeliet, Peter and Yustein, Jason T and Fendt, Sarah-Maria and Uyttebroeck, Anne and Sampaolesi, Maurilio},
title = {miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2024.115171}
}
EUVIMED